首页 | 本学科首页   官方微博 | 高级检索  
     


Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors
Authors:Vinay M Girijavallabhan  Carmen Alvarez  Frank Bennett  Lei Chen  Stephen Gavalas  Yuhua Huang  Seong-Heon Kim  Aneta Kosinski  Patrick Pinto  Razia Rizvi  Randall Rossman  Bandarpalle Shankar  Ling Tong  Francisco Velazquez  Srikanth Venkatraman  Vishal A Verma  Joseph Kozlowski  Neng-Yang Shih  John J Piwinski  Malcolm Maccoss  Cecil D Kwong  Namita Bansal  Jeremy L Clark  Anita T Fowler  Hollis S Kezar  Jacob Valiyaveettil  Robert C Reynolds  Joseph A Maddry  Subramaniam Ananthan  John A Secrist  Cheng Li  Robert Chase  Stephanie Curry  Hsueh-Cheng Huang  Xiao Tong  F George Njoroge  Ashok Arasappan
Affiliation:Merck Research Laboratories, 2015 Galloping Hill Rd., Kenilworth, NJ 07033, USA.
Abstract:Introduction of a nitrogen atom into the benzene ring of a previously identified HCV replication (replicase) benzothiazole inhibitor 1, resulted in the discovery of the more potent pyridothiazole analogues 3. The potency and PK properties of the compounds were attenuated by the introductions of various functionalities at the R(1), R(2) or R(3) positions of the molecule (compound 3). Inhibitors 38 and 44 displayed excellent potency, selectivity (GAPDH/MTS CC(50)), PK parameters in all species studied, and cross genotype activity.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号